Please login to the form below

Not currently logged in
Email:
Password:

Liptruzet

This page shows the latest Liptruzet news and features for those working in and with pharma, biotech and healthcare.

Merck profit slides as generics continue to bite

Merck profit slides as generics continue to bite

Merck is hoping to re-inject growth into the cholesterol franchise with the ongoing roll-out of Liptruzet (ezetimibe and atorvastatin) in the US.

Latest news

  • Merck & Co wins green light in US for Zetia-Lipitor combo Merck & Co wins green light in US for Zetia-Lipitor combo

    Merck &Co has been awarded marketing approval for Liptruzet, a new combination cholesterol treatment based on Zetia and generic atorvastatin. ... Merck is upfront about the capabilities of the new therapy, indicating in its press release that while the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics